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Dear Dr. Hayes,
Re: Séralini, G.-E., et al. Long term toxicity of a Roundup herbi-
cide and a Roundup-tolerant genetically modiﬁed maize. Food
Chem. Toxicol. (2012).
‘‘Science thrives because it is always open to new ideas, so long
as they can survive skeptical scrutiny’’ (Henderson, 2012).
The widely publicised Séralini paper does not survive such scru-
tiny. The authors even went some way to prevent it.
We are concerned that the normally robust scientiﬁc process
has been used to publicise an agenda rather than evidence – as
part a campaign against GM technology.
Only images and data that appeared to tell a particular story
were made available. Even without the full data set, we can high-
light ﬂaws with statistical analysis, study design and anomalous
ﬁndings. In the attached statement we also highlight issues of ani-
mal welfare.
A lack of rigour in the peer review process can be damaging to
the perception of both animal research and the scientiﬁc process as
a whole. It undermines work that promotes good-quality science
supported by high animal welfare standards. By insisting on adher-
ence to standards, such as the NC3Rs ARRIVE guidelines, publica-
tions can ensure that study design and reporting are of sufﬁcient
standard to be interpreted and used by others, helping to ensure
conﬁdence in the scientiﬁc process, and in the methodologies used.
As scientists, it is important for us to help make sure that de-
bate, legislation and policy decisions are based on well-grounded
scientiﬁc evidence. We hope that you can help ensure that the full
data set for this paper is made available, so that the relevance of
the ﬁndings to that process can be established.
Best wishesDale Sanders, Director, The John Innes Centre, UK
e-mail: dale.sanders@jic.ac.uk
Sophien Kamoun, Senior Scientist and Head, The Sainsbury
Laboratory, Norwich Research Park, UK
e-mail: sophien.kamoun@tsl.ac.uk
Bella Williams, Head of Engagement, Understanding Animal
Research, UK
e-mail: awilliams@uar.org.uk
Michael Festing, Visiting Scientist, MRC Toxicology Unit, UK
e-mail: Michaelfesting@aol.com
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Open access under CC BY-NC-ND license.1. Response to paper by Séralini et al. on genetically modiﬁed
maize
1.1. Rat images
The paper showed alarming images of rats with large multiple
tumours. We have two problems with these images. Firstly, for
reasons of animal welfare these animals should have been huma-
nely euthanised earlier. Secondly, the use of these images gives a
distorted perception of the results because images of rats fed
non-GM maize were not made available.
1.2. ARRIVE guidelines
We have evaluated the study against guidelines produced by
NC3Rs, the National Centre for the Replacement, Reﬁnement and
Reduction of Animals in Research. The ARRIVE guidelines have
been produced to improve standards of reporting in scientiﬁc pa-
pers. They help ensure that a paper provides ‘‘key information on
how the study was designed, conducted and analysed’’, without
which its ‘‘value in informing future scientiﬁc studies and policy’’
is limited.
It is recommended that the introduction of a paper should ‘‘in-
clude sufﬁcient scientiﬁc background (including relevant refer-
ences to previous work) to understand the motivation and
context for the study, and explain the experimental approach
and rationale.’’
The authors of the current study state in their introduction that
‘‘there is an ongoing international debate as to the necessary
length of mammalian toxicity studies in relation to the consump-
tion of genetically (GM) plants’’. However, the only evidence used
to substantiate this claim is a paper by the leading author of the
current study.
Further claims made about GMOs reference only papers that in-
clude authors of the current study. This does not constitute ‘‘sufﬁ-
cient scientiﬁc background’’.
Where the current study falls short of the ARRIVE guidelines in
other respects, we have highlighted the shortcomings.1.3. Sprague–Dawley rats
The rats were obtained from Harlan, whose catalogue shows
that the strain used has a survival rate of just over 50% after
2 years. They are susceptible to tumours if kept alive for too long,
even on a standard diet.
This information should be included in the paper. The ARRIVE
guidelines speciﬁcally recommend commenting on ‘‘any limita-
tions of the animal model’’.
The length of study was inappropriate for the strain of rats used,
raising questions of animal welfare as well as helping to invalidate
the ﬁndings.
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A well-known study with 100 rats showed that after 2 years
82% of male and 72% of female rats developed tumours without
administering anything other than normal feed (Kilkenny et al.,
2010; Suzuki et al., 1979; Prejean et al., 1973). Consequently, a
90-day feeding trial is considered sufﬁcient (Davis et al., 1956),
to avoid undue suffering.
The treatments after 2 years in the present study produced no
higher incidence of mortality or tumour incidence than found in
these large cohort studies on a standard diet.
The images and data presented describe a shocking incidence of
tumours in the rats, and for welfare reasons the study should have
been designed to avoid occurrence of these large tumours. Better
study design that employed, for example, imaging techniques to
look at the early development of tumours, would have prevented
this.
Unfortunately, studies which do not meet basic ethical stan-
dards reﬂect on the entire scientiﬁc community, who are too easily
seen by the public as allowing animals to suffer needlessly.
Extending the rats’ lifespan and allowing the tumours to grow so
large established nothing except publicity for the authors and dis-
tress for the animals.
Causing suffering for no meaningful scientiﬁc purpose is unac-
ceptable and would not be permitted under Home Ofﬁce guide-
lines or the Animals (Scientiﬁc Procedures) Act 1986.
1.5. Statistical analysis
The results have not been subjected to standard statistical anal-
ysis (Snell et al., 2012) so it is not possible to reach any conclu-
sions. The interpretations reached by the authors are therefore
seriously ﬂawed and unusable by readers of the article.
For example, the data in Table 2 do not show conﬁdence inter-
vals or provide evidence of signiﬁcant differences between all the
treatments and the controls. No dose–response curves were de-
rived which would help indicate the causes of the claimed increase
in mortality.
It is noticeable that the mortality data were not subjected to an
approved statistical analysis by the authors. However, a statistical
analysis is possible because the mortality can be read from the
plots given in Fig. 1 with reasonable accuracy. This analysis shows
there were no signiﬁcant differences between the controls and the
other groups (see Appendix).
The claim by the authors that ‘‘In females, all treated groups
died 2–3 times more than controls, and more rapidly’’ is not true.
The ARRIVE guidelines recommend providing details of the sta-
tistical methods used for each analysis and describing any methods
used to assess whether the data meet the assumptions of the statis-
tical approach. The current study falls a long way short. They also
recommend reporting the results for each analysis carried out, with
a measure of precision (e.g. standard error or conﬁdence interval).
2. Blinding
Another problem with the design is that there is no mention in
the paper about blinding. It does not look like the treatment allo-
cation was concealed during assessment of the results. This is an-
other source of bias, especially since the presence of tumours seem
to have been assessed manually.
3. Sample size
The numbers in each group are actually too small to perform
the standard methods of statistical analysis required to ﬁnd signif-
icant effects on mortality or tumour rates.As recommended in the ARRIVE guidelines, the authors should
explain how the number of animals was arrived at, providing de-
tails of any power calculations used to determine the number of
animals in each group.
3.1. Controls
The study did not employ adequate controls, for example rats
fed the standard diet not supplemented with maize. Ten rats was
insufﬁcient to lend statistical signiﬁcance to many of the results ci-
ted here, which could have occurred by chance.
The full data on controls are not provided. It is therefore impos-
sible for other scientists to draw full conclusions.
The inadequacy of controls, the lack of statistical analysis and
the inappropriate use of an animal model render the ﬁndings
unusable by readers of the article, either as part of their dataset,
or as background information.
3.2. Isoﬂavones
In an attempt to identify metabolic effects of the transgene, the
authors state that they measured and detected isoﬂavones in the
maize. However, maize does not synthesise isoﬂavones so the
authors should not have been able to detect these compounds. This
calls into question the robustness of the measurements, the anal-
ysis, or the identiﬁcation methods used. Alternatively, the samples
may have been contaminated with soybean or another legume
prior to analysis, which would impact the interpretation of the re-
sults signiﬁcantly.
3.3. Funding
As recommended by the ARRIVE guidelines, the authors should
list all funding sources, including grant number, and the role of the
funders in the study.
3.4. Evidence to the contrary (Davis et al., 1956; Broadhurst and Kell,
2006; Hammond et al., 2004)
In Europe and around the world, tens of millions of farm ani-
mals, including chicken, pigs and cows are fed with GM maize
and soybeans. Since 1996, over 2 trillion meals containing GM
ingredients have been eaten around the world.
The World Health Organisation has said that: ‘‘No effects on hu-
man health have been shown as a result of the consumption of
such foods by the general population in the countries where they
have been approved’’.
3.5. Neutral technology
The authors ignore the fact that genetic modiﬁcation is a tech-
nology. The function of the gene chosen for transformation dictates
its effect. The process of transformation does not. Even if a trait
were somehow toxic this doesn’t translate to GM technology as a
whole.
Appendix A
A.1. Analysis by Michael Festing
There are many serious ﬂaws in this paper and it is surprising
that it has even been considered for publication in a reputable
journal. My comments refer only to the mortality data presented
in Fig. 1. According to the abstract ‘‘The health effects of a Round-
up-tolerant genetically modiﬁed maize (from 11% in the diet), culti-
vated with or without Roundup, and Roundup alone (from 0.1 ppb
Table A1
Mortality of rats fed GMO treated or not with Roundup, and effects of Roundup alone.
Group Male Female Added across sexes and levels p-Value*
Dead Total Dead Total Dead Total % Deaths
GMO C-33% 9 10 2 10 11 20 55
11% 7 10 5 10 37 60 61 0.79
22% 6 10 6 10
33% 6 10 7 10
GMO + R C-33% 9 10 2 10 11 20 55
11% 7 10 5 10 41 60 68 0.41
22% 8 10 7 10
33% 10 10 4 10
R C-33% 9 10 2 10 11 20 55
Low 8 10 7 10 38 60 63 0.69
Med 7 10 5 10
High 6 10 5 10
* Comparison between control deaths and pooled treatment deaths.
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died 2–3 times more than controls, and more rapidly. This difference
was visible in 3 male groups fed GMOs.’’ It is noticeable that the mor-
tality data were not subjected to a statistical analysis by the
authors, presumably because they did not support their hypothesis
that GMO crops are toxic.
However, a statistical analysis is possible because the mortality
can be read from the plots given in Fig. 1 with reasonable accuracy.
(Note that it is normal to present such data as survival rather than
mortality. This would have shown more clearly exactly what was
happening. For example 9/10 of the control males died before
the end of the study, and this would have been more obvious with
a survival curve as it would use more of the white space on the
plot).
Table A1 shows the mortality to the end of the experiment in
each group. The experiment was badly designed with 10 treat-
ment groups of each sex but only 10 animals in each group. There
were far too few controls, and the authors have paid the price.
Numbers are too small to obtain any signiﬁcant differences
among groups without resorting to cherry-picking, so it is neces-
sary to pool across both sexes and dose levels to have any chance
of detecting statistically signiﬁcant differences. The table shows
the controls as C-33% with mortality being 11/20 (nine males
and two females, 55%). The GMO dose groups were 11%, 22%
and 33% GM corn with 37/60 deaths (19 males and 18 females,
61%). There is no signiﬁcant difference (p = 0.79) between the
55% in the controls and 61% in the GMO-fed group. Similarly,
there is no signiﬁcant difference between the controls and the
GMO + R groups. The mortality in the groups given R alone was
no higher than the controls. I am surprised that 9/20 rats con-
sumed Roundup at half the lowest dose used as a weed killer
for their whole life and still survive as well as the controls. This
implies that it is very non-toxic in rats.
Conclusion: There is no evidence that mortality to the end of the
experiment was signiﬁcantly different in the groups of rats fed
either the GMO, GMO + R or when R was administered in
the drinking water at three different levels. The claim by the
authors that ‘‘In females, all treated groups died 2–3 times more than
controls, and more rapidly’’ is not true (allowing for the poor Eng-
lish). I have not yet studied the rest of the paper in detail as the er-
rors noted above alone are sufﬁcient to make the paper unﬁt for
publication.
P.S. I have never had any association with Monsanto or any
other company producing GM crops and have no conﬂict of
interest.Appendix B
B.1. Full comments by Dr. Bella Williams
It is the responsibility of both journals and reviewers to ensure
that published scientiﬁc papers are subject to appropriate scrutiny
and rigour, so that their results may be related to and used by the
rest of the scientiﬁc community. Findings are often cited as evi-
dence by non-scientists, who expect a robust process to ensure
the validity of data.
In the present study the use of controls was clearly inadequate.
Ten rats was insufﬁcient to lend statistical signiﬁcance to many of
the results cited here, which could have occurred by chance. The
length of study was also inappropriate for the strain of rats used.
These points alone render the ﬁndings presented here unusable
by readers of the article, either as part of their dataset, or as back-
ground information. The conclusions of the authors are therefore
misleading.
The images and data presented describe a shocking incidence of
tumours in the rats, and for welfare reasons the study should have
been designed to avoid occurrence of these large tumours. Better
study design that employed, for example, imaging techniques to
look at the early development of tumours, would have prevented
this. Unfortunately, studies which do not meet basic ethical stan-
dards reﬂect on the entire scientiﬁc community, who are too easily
seen by the public as allowing animals to suffer needlessly.
A lack of rigour in the peer review process can be damaging to
the perception of both animal research and the scientiﬁc process as
a whole, undermining the work that promotes good-quality sci-
ence supported by high animal welfare standards. By insisting on
adherence to standards, such as the NC3Rs ARRIVE guidelines, pub-
lications can ensure that study design and reporting is adequate to
be interpreted and used by others, thereby helping to ensure con-
ﬁdence in the scientiﬁc process, and in the methodologies used.
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